Skip to main content
. 2019 Aug 28;62(10):656–672. doi: 10.1002/jlcr.3750

Table 1.

Overview of preclinical SPECT tracers and their characteristics

Author + Year Compound Tumor Model Peptide Dose Activity Dose Tumor Uptake Kidney Uptake
Indium‐111
 Wild et al. 2006 [Lys40(Ahx‐[111In]In‐DTPA)NH2]exendin‐4 RipTag2 and C57BL/6J RipTag2 10 ng (BD)
50 pmol (Im)
185‐370 kBq (BD)
37 MBq (Im)
287 ± 62 %IA/g (4 h) 209 ± 35 %IA/g (4 h)
 Wild et al. 2010 [Lys40(Ahx‐DTPA‐[111In]In)NH2]exendin‐4 RipTag2 10 pmol 70‐110 kBq 213 ± 75 %IA/g (4 h) 243 ± 17 %IA/g (4 h)
 Brom et al. 2012 [Lys40(Ahx‐[111In]In‐DTPA)NH2]exendin‐3 INS‐1 20 pmol 370 kBq 25.0 ± 6.0 %ID/g (30 min)
26.5 ± 8.9 %ID/g (4 h)
150.7 ± 14.9 %ID/g (30 min)
188.8 ± 14.4 %ID/g (4 h)
 Brom et al. 2012 [Lys40(Ahx‐[111In]In‐DTPA)NH2]exendin‐4 INS‐1 20 pmol 370 kBq 30.7 ± 6.1 %ID/g (30 min)
41.9 ± 7.2 %ID/g (4 h)
150.9 ± 9.6 %ID/g (30 min)
173.6 ± 24.3 %ID/g (4 h)
 Brom et al. 2012 [Lys40(Ahx‐[111In]In‐DTPA)NH2]exendin(9‐39) INS‐1 20 pmol 370 kBq 3.2 ± 0.7 %ID/g (30 min)
0.71 ± 0.2 %ID/g (4 h)
65.7 ± 6.1 %ID/g (30 min)
70.7 ± 4.0 %ID/g (4 h)
 Bauman et al. 2015 [Lys40‐(AHX‐DTPA‐[111In]In)NH2]exendin‐4 RIN‐m5f 10 pmol, 52 ng 385 kBq 14.74 ± 5.91 %ID/g (1 h)
15.56 ± 5.32 %ID/g (4 h)
9.31 ± 2.35 %ID/g (24 h)
3.47 ± 0.52 %ID/g (48 h)
152.70 ± 24.86 %ID/g (1 h)
178.41 ± 33.66 %ID/g (4 h)
144.09 ± 20.94 %ID/g (24 h)
84.80 ± 19.26 %ID/g (48 h)
 Kimura et al. 2017 [Lys12([111In]In‐BnDTPA)]exendin‐9‐39 INS‐1 1.5 ng
790 ng
37 kBq/100 μL (BD)
19.9 MBq/220 μL (Im)
7.83 ± 1.86 %ID/g (30 min)
1.87 ± 0.52 %ID/g (4 h)
193.6 ± 15.1 %ID/g (30 min)
180.9 ± 52.7 %ID/g (4 h)
Technetium‐99m
 Wild et al. 2010 [Lys40(Ahx‐HYNIC‐[99mTc]Tc/EDDA)NH2]exendin‐4 RipTag2 10 pmol (BD)
70‐110 kBq (BD)
37 MBq (Im)
67 ± 13 %IA/g (30 min)
93.1 ± 19.9 %IA/g (4 h)
63 ± 10 %IA/g (30 min)
60 ± 12 %IA/g (4 h)
 Medina‐Garcia et al. 2015 [Lys27([99mTc]Tc‐EDDA/HYNIC)]exendin(9‐39) AR42J induced 1.85 MBq 2.41 ± 0.38 %ID/g (2 h) 95.01 ± 1.95 %ID/g (2 h)

Abbreviations: BD, biodistribution; Im, imaging; SPECT, single‐photon emission computed tomography.